Esco Aster
End-to-end bioinnovation from concept to commercial production with GMP-compliant manufacturing and clinical development.
Listed on cdmo.directory
Esco Aster is a vertically integrated CDMO and CRO delivering end-to-end contract solutions from process development and GMP manufacturing through clinical research, with specialized capabilities in vaccine production, cell therapy, plasmid DNA, extracellular vesicles, and GLP toxicology.
Modalities
Services
Indications
About this organization
Overview
Esco Aster is a vertically integrated bioinnovation venture accelerator and contract research and manufacturing organization (CRDMO) delivering end-to-end "idea-to-exit" solutions spanning consultancy, research, CMC development, manufacturing, testing, clinical development, and strategic capital support.
Core Capabilities
Manufacturing & Process Development
- cGMP-compliant vaccine development and manufacturing with single-use solutions, process scale-up/scale-down, and process validation
- Cell bank preservation for cell lines, microbial cells, and biologics
- Cell culture process development and optimization, including medium optimization and seed preparation
- Plasmid DNA manufacturing at preclinical, clinical, and commercial scales with GMP standards
- Aseptic fill-and-finish services (first in Southeast Asia/ASEAN) with USP <1207> container-closure integrity testing and in-house autoclave sterilization
- Advanced formulation solutions for inhalation-based exosome delivery (nasal spray, nebulizer, dry powder)
Therapeutic Modalities
- Vaccine technologies (conventional inactivated, attenuated live, subunit, VLPs, DNA, self-amplifying RNA)
- Cell therapy including CAR-T cells, CAR-NK cells, and CAR-dendritic cells with process design through GMP manufacture
- Extracellular vesicles and exosome therapeutics
- Adherent cell line creation, banking, characterization, and storage
- Plasmid DNA for gene therapy applications
Preclinical & Clinical Services
- GLP Toxicology studies (material production and study oversight) aligned with investment milestones
- Preclinical to clinical testing for drug efficacy determination
- Lead optimization through commercialization support for advanced therapies
- MiniTide® 3D tissue culture platform as parallel to traditional 2D and organoid approaches
Strategic Services
- Strategic capital support and fundraising services
- Business development and enterprise support
- Venture ecosystem partnership
Therapeutic Areas
Serves diagnostics, therapeutics, vaccines, dermatology, dermocosmetics, cosmeceuticals, medical aesthetics, injectables, coatings, nutraceuticals, and cellular agriculture. Demonstrated commercial deployment in human and animal vaccines, dermocosmetics, cell-based nutrition, and clinical-grade stem cells and exosomes.
Certifications
Submit a verified review for this organization.
Markdown mirror: /companies/escoaster.md